ζPρ KSGCZ~i[Μ²Δΰ
@@@@utFProfessor Michael A. Hollingsworth@
@@@@(University of Nebraska Medical Center, Omaha)
| |
θFSignal Transduction @@@by the Cell Surface Mucin MUC1
|
@ϊF½¬QPNRQRϊij16:30|17:30
@κFεw@PKZ~i[Ί
|
| |
MUC1, a transmembrane mucin, is a key modulator of several signaling pathways that affect oncogenesis, motility,
and cell morphology. The interaction of MUC1 cytoplasmic tail (MUC1CT) with signal transducers and its nuclear
translocation and subsequent biological responses are believed to be regulated by phosphorylation status, but the
precise mechanisms by which this occurs remain poorly defined. We detected a novel association between the Met
receptor tyrosine kinase and the MUC1CT. Met catalyzed phosphorylation of tyrosine at YHPM in the MUC1CT.
Stimulation of S2-013.MUC1F pancreatic cancer cells with hepatocyte growth factor facilitated nuclear localization
of MUC1CT, as determined by real time confocal imaging analysis. MUC1 overexpression also facilitated faster
turnover of Met. Phosphorylation of MUC1CT by Met enhanced its interaction with p53, which led to suppression of
AP1 transcription factor activity through interactions at the MMP1 promoter, ultimately leading to reduced
transcription of MMP1. This correlated with a decrease in hepatocyte growth factor-induced invasiveness when
MUC1 was overexpressed. The results demonstrate that MUC1 modulates Met-mediated oncogenic signaling in cancer.
Ref) J. Biol. Chem. 283(40): 26985-26995, 2008
|
Copyright (C) 2008 Kochi System Glcobiology Center , Kochi University. All Rights Reserved
mAζn
§ 783-8505 m§μsͺL¬¬@
mεwγwΆ»wuΐ
TEL: 088-880-2588 FAX: 088-880-2314 
|
|